Determination of serum prostate specific antigen in patients with tumours of prostate and tumour cell lines

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F10%3A00166787" target="_blank" >RIV/62156489:43210/10:00166787 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Determination of serum prostate specific antigen in patients with tumours of prostate and tumour cell lines
Original language description
Tumour markers are biochemical indicators of malignant tumour proliferation. They serve not only for diagnostics of malignant tumour diseases, but also for monitoring of effect of therapy and recurrence of disease. One of the most important indicators ofquality of oncological markers is their sensitivity; it means possibility to detect diseases at the lowest stages, and specifity to given type of tumour. In the case of prostate carcinoma, prostatic acid phosphatase (PAP) was usually used in the past. PAP was replaced at the end of eighties of last century by serum prostate specific antigen (PSA), which belongs to group of the best tumour markers, what are available to medicine at the present.
Czech name
—
Czech description
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2010
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Article name in the collection
X. Pracovní setkání fyzikálních chemiků a elektrochemiků & IV. Letní elektrochemická škola
ISBN
978-80-7375-396-2
ISSN
—
e-ISSN
—
Number of pages
3
Pages from-to
53-55
Publisher name
Mendelu
Place of publication
Brno
Event location
Brno
Event date
Jan 1, 2010
Type of event by nationality
CST - Celostátní akce
UT code for WoS article
—

Similar results(10)